mdlinx mdlinx

Design, methodological issues and participation in a multiple sclerosis case-control study Acta Neurologica Scandinavica, 05/03/2012

Williamson DM et al. – Epidemiological studies play a key role in identifying genetic and environmental factors that are associated with complex diseases like multiple sclerosis (MS). Methodological issues arise in every study, and investigators need to be able to detect, respond to and correct problems in a timely and scientifically valid manner.

Methods
  • Individuals with definite MS were identified from a prevalence study conducted in three geographic areas.
  • The target number of cases was not reached, so an additional study area was added.
  • Identifying clinic controls was inefficient, so controls were recruited using random digit dialing.

Results
  • In total, 276 cases and 590 controls participated, but participation rates were low, ranging from 28.4% to 38.9%.
  • Only one-third (33.6%) of individuals identified in the prevalence study agreed to participate in the case–control study.
  • Cases were more likely to be non-Hispanic white and older than their source populations as identified in the preceding prevalence study (P < 0.05).
  • Most participants provided a blood sample for genotyping (91%; n = 789).

Read this article on Acta Neurologica Scandinavica



Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close